S3E5: Human Capital Due Diligence as a PE Value Creation Lever

S4E3: The Life Sciences IPO Playbook: Key Compensation Decisions Before Going Public

Season 4 of Pearl Meyer Unscripted is looking at executive compensation through an industry lens. In this episode, co-hosts Mark Rosen [https://pearlmeyer.com/our-people/mark-rosen] and Aalap Shah [https://pearlmeyer.com/our-people/aalap-shah] are joined by Rob James [https://pearlmeyer.com/our-people/robert-james] to discuss the key compensation issues life sciences companies should address when preparing to go public.

S4E2: Burn Rate, Dilution, and the Fight for Life Sciences Talent

Season 4 of Pearl Meyer Unscripted is looking at executive compensation through an industry lens. In this episode, co-hosts Mark Rosen [https://pearlmeyer.com/our-people/mark-rosen] and Aalap Shah [https://pearlmeyer.com/our-people/aalap-shah] are joined by Matt Molberger [https://pearlmeyer.com/our-people/matt-molberger] to discuss the key equity strategy “levers” that life sciences companies can use to manage their share burn rates and preserve equity plan pools. Related Content: Looking Beyond Gross Burn Rate in Life Sciences Equity Programs [https://pearlmeyer.com/insights-and-research/article/looking-beyond-gross-burn-rate-in-life-sciences-equity-programs] Inducement Awards in Biopharma [https://pearlmeyer.com/insights-and-research/article/inducement-awards-in-biopharma]

S4E1: Pressure Testing Annual Incentive Programs for Emerging Growth Life Science Companies

Season 4 of Pearl Meyer Unscripted is looking at executive compensation through an industry lens. In the first episode, co-hosts Mark Rosen [https://pearlmeyer.com/our-people/mark-rosen] and Aalap Shah [https://pearlmeyer.com/our-people/aalap-shah] speak with Terry Newth [https://pearlmeyer.com/our-people/terry-newth], the founder of Pearl Meyer's Life Sciences Practice, about creating a balanced annual incentive program and process. Related Content: Incentive Plan Design in Early-Stage Growth Companies: Navigating Goal Adjustments During the Performance Period [https://pearlmeyer.com/insights-and-research/article/incentive-plan-design-in-early-stage-growth-companies] Setting Annual Incentive Compensation Goals in Biotech [https://pearlmeyer.com/insights-and-research/advisor-blog/setting-annual-incentive-compensation-goals-in-biotech]

S3E6: The PE CFO Balancing Act: Play Maker and Game Manager

Today’s private equity CFO must do far more than manage the numbers. In the final episode of Season 3 of Pearl Meyer Unscripted, David Clary and Vamsi Tetali explore why the traditional “game manager” CFO profile breaks down in high-constraint environments, and how strategic CFOs balance capital discipline, liquidity management, and exit readiness—without becoming the “chief no officer.” The conversation covers CEO partnership, FP&A, operational trade-offs, leadership assessment, and what PE sponsors should look for when hiring truly value-creating CFO talent.

S3E5: Human Capital Due Diligence as a PE Value Creation Lever

Early insight into leadership and organizational dynamics can uncover hidden risks, inform stronger deal decisions, and shape value creation from the start. Host David Clary is joined by Kim Kroll and Annie Czarnecki to explore why human capital is often the most under-examined—and most critical—area of private equity diligence. While firms invest heavily in financial and operational analysis, leadership capability, talent, and culture are frequently assessed too late. They discuss how early insight into these factors can challenge assumptions, improve deal decisions, and determine whether a value creation plan is truly executable.